Inovio Pharmaceuticals, Inc.INO announced that the U.S. Defense Advanced Research Projects Agency (DARPA) has exercised its option to provide an additional $24 million for the development of Inovio’s multiple treatment and prevention approaches against Ebola. The Ebola program includes